Skip to content

ALPHA SOINS

Active Private limited companyfounded 2010active for 16 yearsThier de la Rivière 4, 4520 WanzeKBO/BCE: BE 0829.603.881

Timeline

27 events since 2010

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 42 days before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 7 days before the deadline
2024
Registered office moved from Watermael-Boitsfort to WanzeThe registered office moved from Avenue du Martin-Pêcheur 48 boîte 64 à 1170 Watermael-Boitsfort to Thier de la rivière, 4A à 4520 Wanze · Board meeting of 21-10-20242 points ▸
  • Board meeting of 21-10-2024
  • The registered office moved to Thier de la rivière, 4A à 4520 Wanze

Open the deed in the Belgian Official Gazette

Annual accounts 2023 filed PDFmicro format · 33 days late
reappointed as directorGeneral meeting of 07-05-20245 points ▸
  • General meeting of 07-05-2024
  • The capital is divided into 100 shares
  • reappointed as director
  • The registered office is at Avenue du Martin-Pêcheur 48 Boîte 64
  • Power of attorney granted to
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

2023
Back to profit net €17,564 The net result is €17,564, after one loss-making year.
Annual accounts 2022 filed PDFmicro format · 45 days before the deadline
2022
Weakest financial year net -€31,703 The net result drops to -€31,703, the lowest from 2011 to 2025. It recovers the following year.
Annual accounts 2021 filed PDFmicro format · 24 days late
2021
Equity above €150,000 equity €150,716 ▲1.1% After 4 profitable years in a row, equity reaches €150,716.
Annual accounts 2020 filed PDFmicro format · 25 days late
2020
Highest result from 2011 to 2025 net €38,813 ▲253% The net result of €38,813 is the highest of those years.
Annual accounts 2019 filed PDFmicro format · 31 days late
2019
Annual accounts 2018 filed PDFmicro format · 26 days late
2018
Back to profit net €2,718 The net result is €2,718, after one loss-making year.
Liquidity more than doubled current ratio 5.65 The current ratio rises from 2.46 to 5.65. Short-term debt falls from €52,652 to €22,187.
Annual accounts 2017 filed PDFmicro format · 6 days before the deadline
2017
Annual accounts 2016 filed PDFmicro format · 25 days late
2016
Annual accounts 2015 filed PDFfull format · 30 days late
2015
Annual accounts 2014 filed PDFfull format · 4 days late
2014
Equity above €100,000 equity €104,136 ▲33.2% With a profit in every financial year since 2011, equity grows to €104,136.
Annual accounts 2013 filed PDFfull format · 19 days late
2013
Annual accounts 2012 filed PDFfull format · 14 days late
2012
Annual accounts 2011 filed PDFfull format · 7 days late
2011
is in office as manager is a shareholder1 point ▸
  • is a shareholder
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

2010
First establishment Thier de la Rivière 4A, Wanze
IncorporationFounding capital of €18,600, 100 shares, €15,000 paid up · Founded by (comparante) · appointed as manager · published on 06-10-20106 points ▸
  • Founded by
  • The founding capital is €18,600, divided into 100 shares
  • The capital is €18,600, divided into 100 shares
  • General meeting of 24-09-2010
  • appointed as manager, not named in the articles
  • The board has one director
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

ALPHA SOINS was incorporated on 24 September 2010 by one private individual, with a starting capital of €18,600.12 The registered office was moved to Wanze in 2024.3 The board currently has 2 members.4 Total assets rose from €125,998 in 2018 to €191,092 in 2025.5

  1. 1KBO register
  2. 2Belgian Official Gazette, 06-10-2010
  3. 3Belgian Official Gazette, 19-11-2024
  4. 4National Bank, annual accounts 2025
  5. 5National Bank, annual accounts 2018 and 2025

Next steps